Literature DB >> 20883638

Bronchiectasis in primary Sjögren's syndrome: prevalence and clinical significance.

M-J Soto-Cardenas1, M Perez-De-Lis, A Bove, C Navarro, P Brito-Zeron, C Diaz-Lagares, M Gandia, M Akasbi, A Siso, E Ballester, A Torres, M Ramos-Casals.   

Abstract

OBJECTIVES: To analyse the prevalence and clinical significance of bronchiectasis in a large series of patients with primary Sjögren's syndrome (SS) and evaluate its impact on disease expression and outcomes.
METHODS: The study cohort included 507 patients with primary SS. Bronchiectasis were diagnosed according to pulmonary computed tomography (CT). As a control group, we included 37 consecutive SS patients evaluated by pulmonary CT during the same study period without pulmonary involvement.
RESULTS: Fifty primary SS patients had bronchiectasis according to the pulmonary CT. Nine patients were excluded due to non-autoimmune processes and 41 were classified as bronchiectasis associated with primary SS (40 women, mean age of 64 years). All cases of bronchiectasis were of the cylindrical type and were located in the inferior lobes in 29 cases (71%). Patients with bronchiectasis were older at diagnosis of SS (60.39 vs. 52.54 years, p=0.022) and had a higher frequency of hiatus hernia (41% vs. 16%, p=0.024) in comparison with controls. Immunologically, patients with bronchiectasis had a lower frequency of anti-Ro/SS-A antibodies (27% vs. 54%, p=0.022) but a higher frequency of anti-smooth muscle--SMAantibodies (82% vs. 60%, p=0.043). During follow-up, patients with bronchiectasis had a higher frequency of respiratory infections (56% vs. 3%, p<0.001) and pneumonia (29% vs. 3%, p=0.002) in comparison with those without.
CONCLUSIONS: Patients with primary SS and bronchiectasis are characterised by an older age, a high frequency of hiatus hernia, a specific immunologic pattern (low frequency of anti-Ro/SS-A and high frequency of anti-SMA) and during follow-up a much higher frequency of respiratory infections and pneumonia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20883638

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  8 in total

Review 1.  Autoantibodies in Sjögren's Syndrome.

Authors:  Anum Fayyaz; Biji T Kurien; R Hal Scofield
Journal:  Rheum Dis Clin North Am       Date:  2016-06-21       Impact factor: 2.670

2.  Sjogren's Syndrome and Pulmonary Disease.

Authors:  Ruben A Peredo; Scott Beegle
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Prognostic value of Sjögren's syndrome autoantibodies.

Authors:  R Hal Scofield; Anum Fayyaz; Biji T Kurien; Kristi A Koelsch
Journal:  J Lab Precis Med       Date:  2018-10-30

4.  Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Raphaèle Seror; Hendrika Bootsma; Simon J Bowman; Thomas Dörner; Jacques-Eric Gottenberg; Xavier Mariette; Elke Theander; Stefano Bombardieri; Salvatore De Vita; Thomas Mandl; Wan-Fai Ng; Aike Kruize; Athanasios Tzioufas; Claudio Vitali
Journal:  Rheumatology (Oxford)       Date:  2015-07-31       Impact factor: 7.580

5.  Risk of Chronic Obstructive Pulmonary Disease in Female Adults With Primary Sjögren Syndrome: A Nationwide Population-Based Cohort Study.

Authors:  Te-Chun Shen; Biing-Ru Wu; Hsuan-Ju Chen; Cheng-Li Lin; Chang-Ching Wei; Chia-Hung Chen; Chih-Yen Tu; Te-Chun Hsia; Chuen-Ming Shih; Wu-Huei Hsu; Fung-Chang Sung; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

Review 6.  Pulmonary Manifestations of Primary Sjögren's Syndrome: Underlying Immunological Mechanisms, Clinical Presentation, and Management.

Authors:  Sarthak Gupta; Marcela A Ferrada; Sarfaraz A Hasni
Journal:  Front Immunol       Date:  2019-06-12       Impact factor: 7.561

7.  Low Influenza, Pneumococcal and Diphtheria-Tetanus-Poliomyelitis Vaccine Coverage in Patients with Primary Sjögren's Syndrome: A Cross-Sectional Study.

Authors:  Jacques Morel; Hind Letaief; Philippe Guilpain; Xavier Mariette; Bernard Combe; Cédric Lukas
Journal:  Vaccines (Basel)       Date:  2019-12-21

Review 8.  The Role of the Immune Response in the Pathogenesis of Bronchiectasis.

Authors:  Paul T King
Journal:  Biomed Res Int       Date:  2018-03-18       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.